Literature DB >> 14609524

TGF-beta 1 signaling controls retinal pericyte contractile protein expression.

Gregory J Sieczkiewicz1, Ira M Herman.   

Abstract

To define the role of transforming growth factor-beta 1 (TGF-beta 1) in modulating pericyte contractile phenotype, we have ablated the TGF-beta signaling pathway by infection with a retrovirus bearing a TGF-beta type II receptor with a truncated C-terminal intracellular kinase domain (DNT beta RII). While TGF-beta 1 blocks pericyte proliferation and induces the expression of vascular smooth muscle contractile proteins in wild-type pericytes, DNT beta RII-bearing pericytes are neither growth inhibited by TGF-beta 1 nor do they accumulate alpha-smooth muscle actin (alpha-SMA) mRNA or protein. TGF-beta 1 induces expression of the myogenic transcription factor myf-5 and the cyclin-dependent kinase inhibitor p27; we show that these signaling pathways are disrupted in the DNT beta RII-bearing pericytes. These observations demonstrate that the TGF-beta 1 signaling pathway controls pericyte growth state and contractile phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609524     DOI: 10.1016/s0026-2862(03)00055-4

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  32 in total

1.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

Review 2.  The pericyte microenvironment during vascular development.

Authors:  Laura B Payne; Huaning Zhao; Carissa C James; Jordan Darden; David McGuire; Sarah Taylor; James W Smyth; John C Chappell
Journal:  Microcirculation       Date:  2019-05-27       Impact factor: 2.628

3.  Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state.

Authors:  Matthew E Kutcher; Alexey Y Kolyada; Howard K Surks; Ira M Herman
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

Review 4.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

5.  p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.

Authors:  Yoko Takahashi; Takakuni Maki; Anna C Liang; Kanako Itoh; Josephine Lok; Noriko Osumi; Ken Arai
Journal:  Brain Res       Date:  2014-10-22       Impact factor: 3.252

6.  Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?

Authors:  Jennifer T Durham; Brian M Dulmovits; Stephen M Cronk; Anthony R Sheets; Ira M Herman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

7.  A novel population of α-smooth muscle actin-positive cells activated in a rat model of stroke: an analysis of the spatio-temporal distribution in response to ischemia.

Authors:  Varun Sharma; Tina W Ling; Sarah S Rewell; David L Hare; David W Howells; Angela Kourakis; Peter J Wookey
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

8.  Central nervous system pericytes in health and disease.

Authors:  Ethan A Winkler; Robert D Bell; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

9.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

10.  MMP-2 Is Mainly Expressed in Arterioles and Contributes to Cerebral Vascular Remodeling Associated with TGF-β1 Signaling.

Authors:  Ye Hua; Weifeng Zhang; Zhenying Xie; Nanfei Xu; Yunnan Lu
Journal:  J Mol Neurosci       Date:  2015-11-21       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.